[Cytolytic hepatic damage caused by ciprofibrate].
Perault
M C
MC
Fievre
J L
JL
Dejean
C
C
Martin
A
A
Vandel
B
B
D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D058607:Fibric Acids; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008107:Liver Diseases / Q000201:enzymology
D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate
Atteinte hépatique cytolytique associée à la prise de ciprofibrate.